With patient sera, IL-6 expression increased according to muscle loss (IL-6 = 1.07 ± 0.16 for the SS group vs. 0.47 ± 0.15 for the MS group, p < 0.001). The gene discussed is IL6; the disease is myeloid sarcoma.